Forbion will be represented by a 20-member team at the Jefferies Global Healthcare Conference, taking place 16–19 November at The Waldorf Hilton in London.
Attending from Forbion are Managing Partners Dirk Kersten and Sander Slootweg, MSc; General Partners Marco Boorsma, PhD, Nanna Lüneborg, PhD, MBA, Rogier Rooswinkel, PhD, Wouter Joustra, MSc, Jon Edwards, PhD and Dmitrij Hristodorov, PhD; Partners Mathias Vinther, PhD and Regina Salvat, PhD; Operating Partners Gijs van den Brink, MD, PhD and John Montana, PhD, MRSA, together with John McDonald, Operating Partner, Business Development and M&A; Principals Vanessa Carle, PhD, Tim Lohoff, PhD, Audrey Cacaly, MSc, Morgan Haller, MSc and Meike Logtenberg, PhD; and Senior Associates Gilles van Tienderen, PhD and Kanay Khakhria, MD.
On Tuesday 17 November from 12:30–13:15 UK time Regina Salvat, PhD, Partner, will participate in a panel of leading European life sciences venture investors as part of Cooley’s Breakthrough Bootcamp. The discussion will explore how the traditional company-building model is evolving, where investors see the most compelling opportunities, and whether established pathways from venture financing to an IPO or M&A remain fit for purpose.
As Europe’s largest healthcare-dedicated gathering, the conference convenes industry leaders, C-suite executives, investors and leading companies from across biopharma, medical technology, healthcare services and healthcare IT to discuss market trends, innovation and strategic opportunities.
The Jefferies Global Healthcare Conference provides a premier forum for company presentations, fireside discussions and one-on-one meetings, fostering connections that shape the future of the global healthcare industry.